Skip to main content
. Author manuscript; available in PMC: 2009 Dec 27.
Published in final edited form as: Transplantation. 2008 Dec 27;86(12):1695–1701. doi: 10.1097/TP.0b013e31819025e5

Figure 3.

Figure 3

Hematological Effects of Alemtuzumab Induction. White blood cell count 0-150 days (A) and up to two years (B) and absolute lymphocyte count 0-150 days (C) and up to two years (D), following initial Alemtuzumab administration demonstrate profound long lasting depletion. Changes in subject 3 noted at 4-5 months post transplant coincide with change in immunosuppression (see text).